Jazz Pharmaceuticals
JAZZ
#2126
Rank
NZ$12.53 B
Marketcap
$207.35
Share price
-2.11%
Change (1 day)
1.56%
Change (1 year)

Market capitalization of Jazz Pharmaceuticals (JAZZ)

Market cap: NZ$12.53 Billion

As of November 2024 Jazz Pharmaceuticals has a market cap of NZ$12.53 Billion. This makes Jazz Pharmaceuticals the world's 2126th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jazz Pharmaceuticals from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$12.53 B2.37%
2023NZ$12.24 B-22.5%
2022NZ$15.79 B37.8%
2021NZ$11.46 B-10.77%
2020NZ$12.84 B3.26%
2019NZ$12.44 B17.1%
2018NZ$10.62 B-6.51%
2017NZ$11.36 B20.57%
2016NZ$9.42 B-25.12%
2015NZ$12.59 B-0.65%
2014NZ$12.67 B42.23%
2013NZ$8.91 B137.27%
2012NZ$3.75 B79.97%
2011NZ$2.08 B104.71%
2010NZ$1.01 B200.6%
2009NZ$0.33 B315.3%
2008NZ$81.64 M-82.67%
2007NZ$0.47 B

End of Day market cap according to different sources

On Nov 16th, 2024 the market cap of Jazz Pharmaceuticals was reported to be:

NZ$12.53 Billion
by Nasdaq info icon info icon
NZ$12.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.24 M-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$61.61 B 391.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$355.55 B 2,736.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$31.78 B 153.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel